|
MCID: PRK024
|
Parkinson Disease, Juvenile, Type 2 malady |
|
Sources: 33OMIM, 22MalaCards See all sources Export this MalaCard |
MalaCards: Parkinson Disease, Juvenile, Type 2, also known as parkinson disease, is related to parkinson disease-16. An important gene associated with Parkinson Disease, Juvenile, Type 2 is PARK2 (parkinson protein 2, E3 ubiquitin protein ligase (parkin)). The drugs bromocriptine and pergolide have been mentioned in the context of this disorder.
OMIM: 600116 |
|
Sources: 33OMIM, 43UMLS See all sources |
|
Sources: 13GeneCards, 14GeneDecks See all sources |
Diseases related to parkinson disease, juvenile, type 2 by text searches and GeneDecks gene sharing:
|
|
Sources: 33OMIM See all sources |
Clinical features from OMIM: 600116
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for parkinson disease, juvenile, type 2 Drug clinical trials:Search ClinicalTrials for parkinson disease, juvenile, type 2 Search NIH Clinical Center for parkinson disease, juvenile, type 2 Search CenterWatch for parkinson disease, juvenile, type 2 Inferred drug relations via UMLS/NDF-RT:43 28 amantadine, amantadine hydrochloride, benztropine, benztropine mesylate, biperiden, biperiden hydrochloride, biperiden lactate, bromocriptine, bromocriptine mesylate, cabergoline, carbidopa, entacapone, levodopa, pergolide, pergolide mesylate, pramipexole, pramipexole dihydrochloride, ropinirole, ropinirole hydrochloride, selegiline, selegiline hydrochloride, tolcapone, trihexyphenidyl, trihexyphenidyl hydrochloride |
|
|
|
|
|
|
|
|
|
Sources: 1BioGPS See all sources |
  |
|
|
|
|
|
|